{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:30:16Z","timestamp":1772782216482,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1038\/nprot.2007.393","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T18:08:01Z","timestamp":1195150081000},"page":"3016-3021","source":"Crossref","is-referenced-by-count":19,"title":["A model of MPTP-induced Parkinson's disease in the goldfish"],"prefix":"10.1038","volume":"2","author":[{"given":"Orly","family":"Weinreb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussa B H","family":"Youdim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"BFnprot2007393_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02816113","volume":"9","author":"EC Hirsch","year":"1994","unstructured":"Hirsch, E.C. Biochemistry of Parkinson's disease with special reference to the dopaminergic systems. Mol. Neurobiol. 9, 135\u2013142 (1994).","journal-title":"Mol. Neurobiol."},{"key":"BFnprot2007393_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/B978-012525445-8\/50006-0","volume-title":"Neurodegeneration and Neuroprotection in Parkinson's Disease","author":"CW Olanow","year":"1996","unstructured":"Olanow, C.W. & Youdim, M.B. Iron and neurodegeneration: prospects for neuroprotection. in Neurodegeneration and Neuroprotection in Parkinson's Disease (eds. Olanow, C.W., Jenner, P. & Youdim, M.B.) 55\u201369 (Academic Press, London, 1996)."},{"key":"BFnprot2007393_CR3","doi-asserted-by":"crossref","unstructured":"Jellinger, K.A. Post mortem studies in Parkinson's disease\u2014is it possible to detect brain areas for specific symptoms? J. Neural Transm. Suppl. 1\u201329 (1991).","DOI":"10.1007\/978-3-7091-6360-3_1"},{"issue":"3 Suppl 1","key":"BFnprot2007393_CR4","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/ana.410440712","volume":"44","author":"P Jenner","year":"1998","unstructured":"Jenner, P. & Olanow, C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44 (3 Suppl 1): S72\u2013S84 (1998).","journal-title":"Ann. Neurol."},{"issue":"Suppl 1","key":"BFnprot2007393_CR5","first-page":"24","volume":"13","author":"P Jenner","year":"1998","unstructured":"Jenner, P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13 (Suppl 1): 24\u201334 (1998).","journal-title":"Mov. Disord."},{"key":"BFnprot2007393_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","volume":"297","author":"KS McNaught","year":"2001","unstructured":"McNaught, K.S. & Jenner, P. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191\u2013194 (2001).","journal-title":"Neurosci. Lett."},{"key":"BFnprot2007393_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-0404.1989.tb01782.x","volume":"126","author":"MB Youdim","year":"1989","unstructured":"Youdim, M.B., Ben-Shachar, D. & Riederer, P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol. Scand. Suppl. 126, 47\u201354 (1989).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"BFnprot2007393_CR8","first-page":"310","volume":"309","author":"JW Langston","year":"1983","unstructured":"Langston, J.W. & Ballard, P.A. Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N. Engl. J. Med. 309, 310 (1983).","journal-title":"N. Engl. J. Med."},{"key":"BFnprot2007393_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston, J.W., Ballard, P., Tetrud, J.W. & Irwin, I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979\u2013980 (1983).","journal-title":"Science"},{"key":"BFnprot2007393_CR10","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns, R.S. et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4- phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546\u20134550 (1983).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnprot2007393_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","volume":"292","author":"JW Langston","year":"1984","unstructured":"Langston, J.W., Forno, L.S., Rebert, C.S. & Irwin, I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292, 390\u2013394 (1984).","journal-title":"Brain Res."},{"key":"BFnprot2007393_CR12","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1126\/science.6610213","volume":"224","author":"RE Heikkila","year":"1984","unstructured":"Heikkila, R.E., Hess, A. & Duvoisin, R.C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224, 1451\u20131453 (1984).","journal-title":"Science"},{"key":"BFnprot2007393_CR13","first-page":"548","volume":"20","author":"CC Chiueh","year":"1984","unstructured":"Chiueh, C.C. et al. Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. Psychopharmacol. Bull. 20, 548\u2013553 (1984).","journal-title":"Psychopharmacol. Bull."},{"key":"BFnprot2007393_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0014-4886(86)90070-1","volume":"91","author":"JS Schneider","year":"1986","unstructured":"Schneider, J.S., Yuwiler, A. & Markham, C.H. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry. Exp. Neurol. 91, 293\u2013307 (1986).","journal-title":"Exp. Neurol."},{"key":"BFnprot2007393_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.molbrainres.2005.08.014","volume":"141","author":"ET McKinley","year":"2005","unstructured":"McKinley, E.T. et al. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res. Mol. Brain Res. 141, 128\u2013137 (2005).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnprot2007393_CR16","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1460-9568.2005.03988.x","volume":"21","author":"CS Lam","year":"2005","unstructured":"Lam, C.S., Korzh, V. & Strahle, U. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur. J. Neurosci. 21, 1758\u20131762 (2005).","journal-title":"Eur. J. Neurosci."},{"key":"BFnprot2007393_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0006-8993(90)90110-W","volume":"534","author":"A Poli","year":"1990","unstructured":"Poli, A., Guarnieri, T., Facchinetti, F. & Villani, L. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in goldfish brain. Brain Res. 534, 45\u201350 (1990).","journal-title":"Brain Res."},{"issue":"Suppl.","key":"BFnprot2007393_CR18","doi-asserted-by":"publisher","first-page":"275S","DOI":"10.1016\/0197-0186(92)90252-M","volume":"20","author":"MB Youdim","year":"1992","unstructured":"Youdim, M.B. et al. MPTP-induced 'parkinsonism' in the goldfish. Neurochem. Int. 20 (Suppl.): 275S\u2013278S (1992).","journal-title":"Neurochem. Int."},{"key":"BFnprot2007393_CR19","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1096\/fasebj.6.12.1521741","volume":"6","author":"HB Pollard","year":"1992","unstructured":"Pollard, H.B. et al. A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP. FASEB J. 6, 3108\u20133116 (1992).","journal-title":"FASEB J."},{"key":"BFnprot2007393_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0006-8993(97)01272-9","volume":"782","author":"R Lucchi","year":"1998","unstructured":"Lucchi, R. et al. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in goldfish cerebellum: neurochemical and immunocytochemical analysis. Brain Res. 782, 105\u2013112 (1998).","journal-title":"Brain Res."},{"key":"BFnprot2007393_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0361-9230(89)90157-3","volume":"23","author":"JD Adams Jr.","year":"1989","unstructured":"Adams, J.D. Jr., Kalivas, P.W. & Miller, C.A. The acute histopathology of MPTP in the mouse CNS. Brain Res. Bull. 23, 1\u201317 (1989).","journal-title":"Brain Res. Bull."},{"key":"BFnprot2007393_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1471-4159.1985.tb07120.x","volume":"44","author":"H Hallman","year":"1985","unstructured":"Hallman, H., Lange, J., Olson, L., Stromberg, I. & Jonsson, G. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse. J. Neurochem. 44, 117\u2013127 (1985).","journal-title":"J. Neurochem."},{"key":"BFnprot2007393_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/311467a0","volume":"311","author":"RE Heikkila","year":"1984","unstructured":"Heikkila, R.E., Manzino, L., Cabbat, F.S. & Duvoisin, R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311, 467\u2013469 (1984).","journal-title":"Nature"},{"key":"BFnprot2007393_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(85)91729-5","volume":"1","author":"GR Uhl","year":"1985","unstructured":"Uhl, G.R., Javitch, J.A. & Snyder, S.H. Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain. Lancet 1, 956\u2013957 (1985).","journal-title":"Lancet"},{"key":"BFnprot2007393_CR25","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch, J.A., D'Amato, R.J., Strittmatter, S.M. & Snyder, S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173\u20132177 (1985).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnprot2007393_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/0014-5793(85)80713-4","volume":"186","author":"RR Fritz","year":"1985","unstructured":"Fritz, R.R., Abell, C.W., Patel, N.T., Gessner, W. & Brossi, A. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B. FEBS Lett. 186, 224\u2013228 (1985).","journal-title":"FEBS Lett."},{"key":"BFnprot2007393_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/exnr.1998.6995","volume":"155","author":"E Bezard","year":"1999","unstructured":"Bezard, E. et al. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp. Neurol. 155, 268\u2013273 (1999).","journal-title":"Exp. Neurol."},{"key":"BFnprot2007393_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1046\/j.1471-4159.2001.t01-1-00227.x","volume":"77","author":"E Grunblatt","year":"2001","unstructured":"Grunblatt, E., Mandel, S., Maor, G. & Youdim, M.B. Effects of R-apomorphine and S-apomorphine on MPTP-induced nigro-striatal doamine neuronal loss. J. Neurochem. 77, 146\u2013156 (2001).","journal-title":"J. Neurochem."},{"key":"BFnprot2007393_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0014-2999(84)90700-3","volume":"106","author":"G Cohen","year":"1984","unstructured":"Cohen, G. et al. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys. Eur. J. Pharmacol. 106, 209\u2013210 (1984).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnprot2007393_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1006\/exnr.1996.0188","volume":"142","author":"HB Pollard","year":"1996","unstructured":"Pollard, H.B., Kuijpers, G.A., Adeyemo, O.M., Youdim, M.B. & Goping, G. The MPTP-induced parkinsonian syndrome in the goldfish is associated with major cell destruction in the forebrain and subtle changes in the optic tectum. Exp. Neurol. 142, 170\u2013178 (1996).","journal-title":"Exp. Neurol."},{"key":"BFnprot2007393_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0014-2999(93)90897-Q","volume":"240","author":"OM Adeyemo","year":"1993","unstructured":"Adeyemo, O.M., Youdim, M.B., Markey, S.P., Markey, C.J. & Pollard, H.B. L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish. Eur. J. Pharmacol. 240, 185\u2013193 (1993).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnprot2007393_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2006.07.020","volume":"25","author":"Y Sagi","year":"2007","unstructured":"Sagi, Y., Mandel, S., Amit, T. & Youdim, M.B. Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism. Neurobiol. Dis. 25, 35\u201344 (2007).","journal-title":"Neurobiol. Dis."},{"key":"BFnprot2007393_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000115856","volume":"35","author":"PJ Hornby","year":"1990","unstructured":"Hornby, P.J. & Piekut, D.T. Distribution of catecholamine-synthesizing enzymes in goldfish brains: presumptive dopamine and norepinephrine neuronal organization. Brain Behav. Evol. 35, 49\u201364 (1990).","journal-title":"Brain Behav. Evol."},{"key":"BFnprot2007393_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF00234878","volume":"208","author":"AH Watson","year":"1980","unstructured":"Watson, A.H. The distribution of aminergic neurones and their projections in the brain of the teleost, Myoxocephalus scorpius. Cell Tissue Res. 208, 299\u2013312 (1980).","journal-title":"Cell Tissue Res."},{"key":"BFnprot2007393_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0006-8993(95)00391-3","volume":"687","author":"G Goping","year":"1995","unstructured":"Goping, G., Pollard, H.B., Adeyemo, O.M. & Kuijpers, G.A. Effect of MPTP on dopaminergic neurons in the goldfish brain: a light and electron microscope study. Brain Res. 687, 35\u201352 (1995).","journal-title":"Brain Res."},{"key":"BFnprot2007393_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molbrainres.2004.06.008","volume":"128","author":"B Hibbert","year":"2004","unstructured":"Hibbert, B. et al. Increased GAD67 mRNA levels are correlated with in vivo GABA synthesis in the MPTP-treated catecholamine-depleted goldfish brain. Brain Res. Mol. Brain Res. 128, 121\u2013130 (2004).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnprot2007393_CR37","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski, S. et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J. Neurochem. 76, 1265\u20131274 (2001).","journal-title":"J. Neurochem."},{"key":"BFnprot2007393_CR38","first-page":"563","volume":"38","author":"SC Yang","year":"1988","unstructured":"Yang, S.C., Markey, S.P., Bankiewicz, K.S., London, W.T. & Lunn, G. Recommended afe practices for using the neurotoxin MPTP in animal experiments. Lab Anim. Sci. 38, 563\u2013567 (1988).","journal-title":"Lab Anim. Sci."},{"key":"BFnprot2007393_CR39","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/jm00146a005","volume":"28","author":"J Weissman","year":"1985","unstructured":"Weissman, J. et al. Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions. J. Med. Chem. 28, 997\u20131001 (1985).","journal-title":"J. Med. Chem."}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nprot.2007.393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nprot.2007.393","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nprot.2007.393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:07:08Z","timestamp":1684454828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nprot.2007.393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["BFnprot2007393"],"URL":"https:\/\/doi.org\/10.1038\/nprot.2007.393","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}